Photo from wikipedia
Existing biomedical HIV prevention options, though highly effective, present substantial adherence challenges. End‐user input on early‐stage design of new HIV prevention approaches is critical to yielding products that achieve high… Click to show full abstract
Existing biomedical HIV prevention options, though highly effective, present substantial adherence challenges. End‐user input on early‐stage design of new HIV prevention approaches is critical to yielding products that achieve high uptake and adherence. The iPrevent Study examined youths’ preferences for key attributes of long‐acting Pre‐Exposure Prophylaxis (PrEP), with a focus on characteristics pertinent to product delivery alongside key modifiable product attributes.
Keywords:
hiv prevention;
acting pre;
exposure prophylaxis;
long acting;
pre exposure;
prevention
Journal Title: Journal of the International AIDS Society
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the International AIDS Society
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!